ANEMIA OF RHEUMATOID ARTHRITIS

类风湿性关节炎贫血

• 批准号: 3905744
• 负责人: EDWARD FUDMAN
• 金额: --
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3905744
• 关键词: anemia; blood disorder chemotherapy; deferoxamine; dosage; drug administration rate /duration; hemoglobin; human subject; human therapy evaluation; rheumatoid arthritis

This is a double-blind, placebo-controlled study of the effect of a single dose of deferoxamine 1 gm IM on the anemia patients with rheumatoid arthritis. Patients who respond to deferoxamine with an increase in hemoglobin at two weeks will be followed for eight weeks to determine the duration of the response.

这是一项双盲、安慰剂对照研究， 单剂量去铁胺1 gm IM治疗贫血患者， 类风湿关节炎对去铁胺有反应的患者 两周时血红蛋白的增加将被跟踪八周， 确定响应的持续时间。